We must take allergies seriously in Parliament if we are to protect those affected on the outside

One in three parliamentarians has an allergy. And yet when Allergy UK, the nation’s leading patient charity on allergy, held a reception in Parliament recently, even the parliamentary authorities struggled to cater for many of the attendees with food allergies.

That’s not a criticism of the parliamentary catering service, it’s a demonstration of how difficult life can be for those with allergies and how it’s high time the condition was taken more seriously.

There ought to be plenty of appetite in Parliament to tackle this. A survey of parliamentarians by YouGov, commissioned by Allergy UK, showed that 30 per cent of MPs have an allergy and 61 per cent have a close friend or family member with an allergy.

Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. 

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

More articles like this

Allergens dominate UK food recalls, finds study

More than half of food recalls in the United Kingdom over a 5-year period were due to allergens, according to a recently released study. Allergen-related recalls increased annually until 2019, peaking at 118 before decreasing to 82 and

Pret a Manger allergy death prompts new reporting system

The family of a Melksham mum of five who died after eating a Pret a Manger sandwich containing a dairy ingredient have backed a coroner’s call for a ‘robust system’ of recording serious cases of anaphylactic shock. Celia

Allergy Therapeutics welcomes new Non-Executive Directors

Allergy Therapeutics announced the appointments of Anthony Parker and Simon Shen to its Board as Non-Executive Directors effective immediately. “I would like to welcome Anthony and Simon. Southern Fox and ZQ Capital have been long-standing and supportive shareholders of Allergy over many

Allergy Therapeutics updates on its clinical programmes

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced that the first subject has been dosed in the pivotal Phase III G306 trial, to evaluate the efficacy and safety of Grass MATA

Allergy Therapeutics appoints two Non-Executive Directors

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has today announced the appointments of Anthony Parker and Zheqing (Simon) Shen as Non-Executive Directors of the Company, with immediate effect. Anthony represents Southern Fox

Allergies and Thanksgiving

As Thanksgiving and other holiday celebrations bring people around the table, Intermountain Healthcare dietitians say it’s crucial to take food allergies into consideration when planning the big meal. “A response to an allergic reaction can be mild, like

Allergy Therapeutics appoints Martin Hopcroft as interim CFO

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced the appointment of Martin Hopcroft to the role of Interim Chief Financial Officer (CFO). Martin will report into Chief Executive Officer, Manuel

Food business operator fined for allergy breach

A food business operator based in Newcastle, England has been fined in court after serving a dish containing peanuts to a woman with a peanut allergy, resulting in her being hospitalised. According to the Food Standards Agency (FSA),

Restaurant fined after peanut allergy teen suffered shock

A restaurant operator who served a curry containing nuts to a woman with an allergy has been fined. Eleanor Lincoln suffered anaphylactic shock after eating the takeaway for her 18th birthday in March 2021. She was treated in

Are restaurants taking allergies seriously?

In an engaging panel held at Twickenham Stadium as part of New Food’s Food Safety Conference 2022, experts came together to debate whether food allergy regulations in restaurants are sufficient. Here’s the highlights. Are restaurant allergy restrictions too

Allergy Therapeutics Subscription to raise £7 million

Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy immunotherapy, today announces a conditional Subscription by the Subscribers, Southern Fox and ZQ Capital (acting through its affiliate SkyGem), to raise £7 million at an

No more posts to show